Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade

Baraibar-Argota, I. (Iosune)

Autor(es):

Baraibar-Argota, I. (Iosune)

Director:

Gil-Bazo, I. (Ignacio)

Palabras clave :

Materias Investigacion::Ciencias de la Salud::Oncología
Cáncer de pulmón
Lung cancer

Fecha de publicación :

8-jun-2021

Fecha de la defensa:

22-jun-2021

Editorial :

Universidad de Navarra

Cita:

BARAIBAR ARGOTA, Iosune. “Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade". Gil, I. (dirs.). Tesis doctoral. Universidad de Navarra, Pamplona, 2021.

Resumen

According to the Global Cancer Observatory (http://gco.iarc.fr), primary lung cancer ranks as the most common tumor worldwide and the leading cause of cancer-related mortality. In 2020, 2.2 million new lung cancer cases were diagnosed, which comprises 12.2% of total cancers.

URI :

https://hdl.handle.net/10171/61070

Aparece en las colecciones:

DA - Medicina - Tesis doctorales
Facultad de Medicina - Tesis Doctorales y Tesinas - 2020-2029

Ficheros en este ítem: